Cellular Immunotherapy Market Size, Share & Trends Report

Cellular Immunotherapy Market Size, Share & Trends Analysis Report By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), By Indication (B-cell Malignancies, Prostate Cancer), By End-use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-952-1
  • Number of Pages: 165
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Market Segmentation

  • Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
    • CAR T Cell Therapy
    • Dendritic Cell Therapy
    • NK Cell Therapy
    • TIL Therapy
    • Others
  • Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018 - 2030)
    • B-cell Malignancies
    • Prostate Cancer
    • Liver Cancer
    • Renal Cell Carcinoma
    • Others
  • Cellular Immunotherapy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Cancer Institutes
    • Others
  • Cellular Immunotherapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • North America Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • North America Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
      • U.S.
        • U.S. Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • U.S. Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • U.S. Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Canada
        • Canada Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Canada Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Canada Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
    • Europe
      • Europe Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Europe Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Europe Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
      • U.K.
        • U.K. Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • U.K. Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • U.K. Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Germany
        • Germany Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Germany Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Germany Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • France
        • France Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • France Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • France Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Italy
        • Italy Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Italy Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Italy Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Spain
        • Spain Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Spain Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Spain Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Russia
        • Russia Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Russia Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Russia Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
    • Asia Pacific
      • Asia Pacific Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Asia Pacific Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Asia Pacific Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
      • Japan
        • Japan Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Japan Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Japan Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • China
        • China Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • China Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • China Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • India
        • India Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • India Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • India Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Australia
        • Australia Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Australia Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Australia Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • South Korea
        • South Korea Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • South Korea Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • South Korea Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
    • Latin America
      • Latin America Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Latin America Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Latin America Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
      • Brazil
        • Brazil Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Brazil Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Brazil Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Mexico
        • Mexico Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Mexico Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Mexico Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Argentina
        • Argentina Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Argentina Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Argentina Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
    • MEA
      • MEA Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • MEA Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • MEA Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
      • South Africa
        • South Africa Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • South Africa Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • South Africa Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • Saudi Arabia
        • Saudi Arabia Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • Saudi Arabia Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • Saudi Arabia Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others
      • UAE
        • UAE Cellular Immunotherapy Market, By Therapy Type
          • CAR T Cell Therapy
          • Dendritic Cell Therapy
          • NK Cell Therapy
          • TIL Therapy
          • Others
        • UAE Cellular Immunotherapy Market, By Indication
          • B-cell Malignancies
          • Prostate Cancer
          • Liver Cancer
          • Renal Cell Carcinoma
          • Others
        • UAE Cellular Immunotherapy Market, By End Use
          • Hospitals
          • Cancer Institutes
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon